...
首页> 外文期刊>BMC Biotechnology >Functional expression of a blood tolerant laccase in Pichia pastoris
【24h】

Functional expression of a blood tolerant laccase in Pichia pastoris

机译:毕赤酵母中耐血漆酶的功能表达

获取原文

摘要

Background Basidiomycete high-redox potential laccases (HRPLs) working in human physiological fluids (pH 7.4, 150 mM NaCl) arise great interest in the engineering of 3D-nanobiodevices for biomedical uses. In two previous reports, we described the directed evolution of a HRPL from basidiomycete PM1 strain CECT 2971: i) to be expressed in an active, soluble and stable form in Saccharomyces cerevisiae , and ii) to be active in human blood. In spite of the fact that S. cerevisiae is suited for the directed evolution of HRPLs, the secretion levels obtained in this host are not high enough for further research and exploitation. Thus, the search for an alternative host to over-express the evolved laccases is mandatory. Results A blood-active laccase (ChU-B mutant) fused to the native/evolved α-factor prepro-leader was cloned under the control of two different promoters (PAOX1 and PGAP) and expressed in Pichia pastoris . The most active construct, which contained the PAOX1 and the evolved prepro-leader, was fermented in a 42-L fed-batch bioreactor yielding production levels of 43 mg/L. The recombinant laccase was purified to homogeneity and thoroughly characterized. As happened in S. cerevisiae, the laccase produced by P. pastoris presented an extra N-terminal extension (ETEAEF) generated by an alternative processing of the α-factor pro-leader at the Golgi compartment. The laccase mutant secreted by P. pastoris showed the same improved properties acquired after several cycles of directed evolution in S. cerevisiae for blood-tolerance: a characteristic pH-activity profile shifted to the neutral-basic range and a greatly increased resistance against inhibition by halides. Slight biochemical differences between both expression systems were found in glycosylation, thermostability and turnover numbers. Conclusions The tandem-yeast system based on S. cerevisiae to perform directed evolution and P. pastoris to over-express the evolved laccases constitutes a promising approach for the in vitro evolution and production of these enzymes towards different biocatalytic and bioelectrochemical applications.
机译:背景技术在人类生理液(pH 7.4,150 mM NaCl)中工作的担子菌高氧化还原电位漆酶(HRPL)引起了对生物医学用途的3D纳米生物装置工程的极大兴趣。在之前的两个报告中,我们描述了来自担子菌PM1菌株CECT 2971的HRPL的定向进化:i)在酿酒酵母中以活性,可溶和稳定的形式表达,ii)在人血中具有活性。尽管酿酒酵母适合于HRPL的定向进化,但是在该宿主中获得的分泌水平还不足以进一步研究和开发。因此,寻找替代宿主以过度表达进化的漆酶是必须的。结果在两个不同的启动子(P AOX1 和P GAP <)的控制下克隆了融合有天然活性/进化的α-因子prepro-leader的具有血液活性的漆酶(ChU-B突变体)。 / sub>),并以毕赤酵母表达。最活跃的构建体包含P AOX1 和进化的pre-pro-leader,在42升补料分批生物反应器中发酵,生产水平为43 mg / L。将重组漆酶纯化至同质并充分表征。正如酿酒酵母中发生的那样,巴斯德毕赤酵母产生的漆酶表现出一个额外的N端延伸(ETEAEF),该延伸是通过在高尔基体中的α因子前导分子的替代加工而产生的。巴斯德毕赤酵母分泌的漆酶突变体显示出相同的改良特性,这些突变是在酿酒酵母中针对血液耐受性的几个定向进化循环后获得的:特征性pH活性曲线移至中性碱性范围,并且极大地增强了其对抑制细菌的抵抗力卤化物。两个表达系统之间的生化差异在糖基化,热稳定性和周转数方面均发现。结论基于酿酒酵母的串联酵母系统可进行定向进化,而巴斯德毕赤酵母则过量表达已进化的漆酶,为这些酶的体外进化和生产提供了一种有前途的方法,可用于不同的生物催化和生物电化学应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号